Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.2415
+0.0042 (1.77%)
At close: Aug 13, 2025, 4:00 PM
0.2417
+0.0002 (0.08%)
Pre-market: Aug 14, 2025, 9:02 AM EDT
Renovaro Market Cap
Renovaro has a market cap or net worth of $55.77 million as of August 14, 2025. Its market cap has decreased by -67.82% in one year.
Market Cap
55.77M
Enterprise Value
61.71M
1-Year Change
-67.82%
Ranking
Category
Stock Price
$0.24
Market Cap Chart
Since December 11, 2018, Renovaro's market cap has decreased from $252.00M to $55.77M, a decrease of -77.87%. That is a compound annual growth rate of -20.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 41.50M | -68.73% |
| Dec 31, 2024 | 132.70M | -37.23% |
| Dec 29, 2023 | 211.40M | 287.89% |
| Dec 30, 2022 | 54.50M | -85.68% |
| Dec 31, 2021 | 380.70M | 176.67% |
| Dec 31, 2020 | 137.60M | -40.77% |
| Dec 31, 2019 | 232.30M | -8.25% |
| Dec 31, 2018 | 253.20M | 0.48% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |